Could chemo before surgery beat cancer better?
NCT ID NCT07492225
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two treatments for a rare type of urinary tract cancer. One group gets chemotherapy before surgery, the other has surgery alone. The goal is to see if chemo helps shrink the tumor and improve long-term outcomes. About 120 adults with high-risk, non-spread cancer are taking part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOADJUVANT THERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Changhai Hospital
Shanghai, Shanghai Municipality, 200090, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Four-Drug combo erase Triple-Negative breast cancer before surgery?
- Can a triple threat of drug, immunotherapy, and radiation wipe out High-Risk urinary tract cancer before surgery?
- Could a Triple-Drug attack before surgery eliminate more breast cancer in older women?
- Modified herpes virus joins forces with immunotherapy to attack head and neck tumors
- Scientists create new tools to fight rare urinary tract cancer
- New targeted pill could boost lung cancer surgery success